Company profile for Innocoll Pharmaceuticals Limited

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Innocoll is a specialty pharmaceutical company focused on the development and commercialization of pharmaceutical technologies to meet some of today’s most important healthcare challenges. We utilize our proprietary collagen-based technology platform to develop biodegradable and fully resorbable products. Our processes and technologies enable us to control the drug elution dynamics, texture, consistency, resorption time and ...
Innocoll is a specialty pharmaceutical company focused on the development and commercialization of pharmaceutical technologies to meet some of today’s most important healthcare challenges. We utilize our proprietary collagen-based technology platform to develop biodegradable and fully resorbable products. Our processes and technologies enable us to control the drug elution dynamics, texture, consistency, resorption time and other physical characteristics of the finished product. All of our native collagen products are manufactured at our certified, state-of-the-art, fully integrated plant in Saal, Germany.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Ireland
Address
Address
Unit 9, Block D, Monksland Business Park, Monksland, Athlone, Co. Roscommon
Telephone
Telephone
+353 (0) 90 6486834
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/innocoll-and-durect-announce-us-launch-of-posimir-301632764.html

PRNEWSWIRE
26 Sep 2022

https://www.businesswire.com/news/home/20220706005105/en

BUSINESSWIRE
06 Jul 2022

https://www.businesswire.com/news/home/20220302005437/en

BUSINESSWIRE
02 Mar 2022

https://www.prnewswire.com/news-releases/innocoll-announces-commercial-launch-of-xaracoll-bupivacaine-hci-implant-a-non-opioid-drug-device-treatment-option-for-acute-postsurgical-pain-relief-for-up-to-24-hours-following-open-inguinal-hernia-repair-in-adults-301163002.html

PRNEWSWIRE
29 Oct 2020

https://www.prnewswire.com/news-releases/innocoll-announces-commercial-launch-of-xaracoll-bupivacaine-hci-implant-a-non-opioid-drug-device-treatment-option-for-acute-postsurgical-pain-relief-for-up-to-24-hours-following-open-inguinal-hernia-repair-in-adults-301163002.html

PRNEWSWIRE
29 Oct 2020

https://www.biospace.com/article/releases/fda-approves-xaracoll-bupivacaine-hcl-implant-a-non-opioid-drug-device-treatment-option-for-acute-postsurgical-pain-relief-for-up-to-24-hours-following-open-inguinal-hernia-repair-in-adults/?s=74

BIOSPACE
31 Aug 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty